Charles R. Shideman
Expertise in
27
conditions

Dr. Charles R. Shideman

Radiation Oncology
Minneapolis Radiation Oncology - Regions
Jackson, MN 
Accepting New Patients
Offers Telehealth
Expertise in
27
conditions
Minneapolis Radiation Oncology - Regions
Jackson, MN 

Overview

Charles Shideman is a Radiation Oncologist practicing medicine in Jackson, Minnesota.

Dr. Shideman is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Posterior Fossa Tumor, Lung Cancer, Pleuropulmonary Blastoma, Familial Prostate Cancer, and Prostatectomy.

Dr. Shideman is board certified in Radiation Oncology and American Board Of Radiology,2013. He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 8 clinical trials. Dr. Shideman is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in MN

Board Certifications

Radiation Oncology
American Board Of Radiology,2013

Hospital Affiliations

Regions Hospital
Lakeview Memorial Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthPartners
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Primewest Health System
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Minneapolis Radiation Oncology - Regions
Jackson, MN 55101

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Enrollment Status: Suspended
Publish Date: September 01, 2026
Intervention Type: Procedure, Drug, Other, Radiation, Biological
Study Drugs: Atezolizumab, Cetuximab, Cisplatin, Docetaxel
Study Phase: Phase 2/Phase 3
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Cisplatin, Fluorouracil, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Enrollment Status: Active_not_recruiting
Publish Date: August 27, 2026
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Atezolizumab, Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 3
Phase III Randomized Trial of Proton Beam Therapy (PBT) Versus Intensity Modulated Photon Radiotherapy (IMRT) for the Treatment of Esophageal Cancer
Phase III Randomized Trial of Proton Beam Therapy (PBT) Versus Intensity Modulated Photon Radiotherapy (IMRT) for the Treatment of Esophageal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 24, 2026
Intervention Type: Drug, Procedure, Radiation, Other
Study Drugs: Carboplatin, Paclitaxel, FOLFOX regimen, CAPOX regimen, Docetaxel, 5FU
Study Phase: Phase 3
Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE*) *INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy
Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE*) *INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy
Enrollment Status: Active_not_recruiting
Publish Date: August 17, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Abiraterone acetate, Apalutamide, Hormone therapy, Prednisone
Study Phase: Phase 3
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Enrollment Status: Active_not_recruiting
Publish Date: August 17, 2026
Intervention Type: Drug, Procedure, Other, Radiation
Study Drugs: Abiraterone acetate, Apalutamide, Bicalutamide, Buserelin, Degarelix, Flutamide, Goserelin, Histrelin, Leuprolide, Prednisone, Triptorelin
Study Phase: Phase 3
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Enrollment Status: Completed
Publish Date: June 25, 2026
Intervention Type: Drug, Other, Radiation
Study Drugs: Bicalutamide, Docetaxel, Flutamide, Goserelin acetate, Leuprolide acetate, Nilutamide
Study Phase: Phase 2/Phase 3
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
View 7 Less Clinical Trials

1 Total Publications

Management of Unplanned Excision for Soft-Tissue Sarcoma With Preoperative Radiotherapy Followed by Definitive Resection.
Management of Unplanned Excision for Soft-Tissue Sarcoma With Preoperative Radiotherapy Followed by Definitive Resection.
Journal: American journal of clinical oncology
Published: June 01, 2014
Similar Doctors
Expertise in
17
conditions
Dr. Elizabeth H. Cameron
Radiation Oncology
Expertise in
17
conditions
Dr. Elizabeth H. Cameron
Radiation Oncology
Referral may be required
420 Delaware St Se, Mmc 494, 
Minneapolis, MN 
 (7.2 miles away)
612-273-8383
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Elizabeth Cameron is a Radiation Oncologist practicing medicine in Minneapolis, Minnesota. Dr. Cameron is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Plasmacytoma, Primitive Neuroectodermal Tumor (PNET), and Posterior Fossa Tumor. Dr. Cameron is currently accepting new patients.

Expertise in
20
conditions
Dr. Kathryn E. Dusenbery
Radiation Oncology | Oncology | Radiology
Expertise in
20
conditions
Dr. Kathryn E. Dusenbery
Radiation Oncology | Oncology | Radiology
Referral may be required

University Of Minnesota Physicians

720 Washington Ave Se, Suite 200, 
Minneapolis, MN 
 (6.9 miles away)
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kathryn Dusenbery is a Radiation Oncologist and an Oncologist practicing medicine in Minneapolis, Minnesota. She has been practicing medicine for over 44 years. Dr. Dusenbery is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Adult Soft Tissue Sarcoma, Rhabdomyosarcoma Embryonal, and Gamma Knife Radiosurgery. Dr. Dusenbery is board certified in Internal Medicine: American Board Of Internal Medicine, 1985, Radiation Oncology: American Board Of Radiology, 1991, and Medical Oncology: American Board Of Internal Medicine, 1987. Dr. Dusenbery is currently accepting new patients.

Expertise in
21
conditions
Dr. Xin Y. Wang
Radiation Oncology
Expertise in
21
conditions
Dr. Xin Y. Wang
Radiation Oncology
Referral may be required

M Health Fairview Radiation Oncology Maplewood

1575 Beam Avenue, 
Maplewood, MN 
 (6.0 miles away)
651-232-7970
Experience:
44+ years
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients

Xin Wang is a Radiation Oncologist practicing medicine in Maplewood, Minnesota. He has been practicing medicine for over 44 years. Dr. Wang is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Posterior Fossa Tumor. Dr. Wang is board certified in Radiation Oncology: American Board Of Radiology, 1997. Dr. Wang is currently accepting new patients.

Frequently Asked Questions about Dr. Charles R. Shideman

How do I make an appointment with Dr. Charles R. Shideman?

You can book an appointment with Dr. Charles R. Shideman by calling their office at 651-254-2039. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Charles R. Shideman a top-rated expert for Posterior Fossa Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Charles R. Shideman is classified as an Distinguished expert for Posterior Fossa Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Charles R. Shideman specialize in?

While Dr. Charles R. Shideman is a Radiation Oncology, they have specific expertise in Posterior Fossa Tumor, Lung Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Charles R. Shideman participate in research or clinical trials?

Yes. Dr. Charles R. Shideman has published 1 articles and abstracts on conditions like Posterior Fossa Tumor. You can view a list of Dr. Charles R. Shideman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Charles R. Shideman accept my insurance?

Dr. Charles R. Shideman accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 651-254-2039 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shideman's expertise for a condition
ConditionClose
    View All 26 Advanced Conditions
    View All 71 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile